<DOC>
	<DOCNO>NCT02602899</DOCNO>
	<brief_summary>Evaluate long-term clinical effectiveness safety PINS Deep Brain Stimulation patient refractory epilepsy .</brief_summary>
	<brief_title>Deep Brain Stimulation Anterior Nucleus Thalamus Refractory Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>age 1260. try least two appropriate antiepileptic drug ( AEDs ) test tolerance blood level upper end target range least 2 tolerate normal dose . least 6 seizure per month . good health except epilepsy . normal MMSE score patient ( ) family could understand method sign inform consent 7）Patients good compliance could complete postoperative followup result MRI remind epilepsy cause intracranial spaceoccupying lesion . vagus nerve lesion damage tumor , cardiopulmonary anomaly , progressive neurological disease , asthma，mental disease，peptic ulcer，diabetes Type 1，bad health etc , surgical contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PINS</keyword>
	<keyword>Deep Brain Stimulator</keyword>
	<keyword>Refractory Epilepsy</keyword>
	<keyword>Anterior Thalamic Nucleus</keyword>
</DOC>